Literature DB >> 18050367

T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.

Xiaomei Li1, Xiangpei Li, Long Qian, Guosheng Wang, Hong Zhang, Xiaoqiu Wang, Ke Chen, Zhimin Zhai, Qing Li, Yiping Wang, David C H Harris.   

Abstract

OBJECTIVE: To investigate the abnormalities of T regulatory cells (Treg) in salivary glands and peripheral blood in patients with primary Sjögren's syndrome (pSS).
METHODS: Levels of CD4+CD25+ high T cells of the peripheral blood of 52 patients with pSS were measured by flow-cytometric assay. Lower lip salivary gland biopsies were examined by immunohistochemistry, using monoclonal mouse anti-human antibodies [CD25, CD4, CD8, CD68, forkhead transcription factor (Foxp3)] in 30 patients with pSS. Using real-time polymerase chain reaction, Foxp3 messenger RNA expression was assessed in the salivary glands and CD4+ T cells from peripheral blood.
RESULTS: Many inflammatory cells, predominantly CD4+ and CD8+ T cells and macrophages, were found in salivary glands of patients with SS, but CD4+CD25+ Treg numbers and Foxp3 expression were markedly reduced in those biopsy samples. Levels of CD4+CD25+ high T cells and Foxp3 expression in peripheral blood of patients with pSS were significantly lower than in healthy controls. However, the inhibitory function of CD4+CD25+ T cells in pSS was unchanged compared to that of controls. Peripheral CD4+CD25+ high T cell numbers in pSS did not correlate with Schirmer's test and salivary flow rate, or with the presence or absence of anti-SSA/SSB antibodies and immunoglobulin level.
CONCLUSION: The remarkable reduction of Treg numbers in salivary glands and reduction of CD4+CD25+ high T cells in peripheral blood suggests a possible role for absence of Treg in the pathogenesis of salivary gland destruction in pSS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18050367

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  31 in total

1.  Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease.

Authors:  Jagadeesh Bayry; Luc Mouthon; Srini V Kaveri
Journal:  J Rheumatol       Date:  2012-02       Impact factor: 4.666

Review 2.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 3.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

4.  Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome.

Authors:  P Szodoray; G Papp; I F Horvath; S Barath; S Sipka; B Nakken; M Zeher
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

5.  Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.

Authors:  Maria I Christodoulou; Efstathia K Kapsogeorgou; Niki M Moutsopoulos; Haralampos M Moutsopoulos
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

6.  STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren's syndrome.

Authors:  Kwong Tai Cheng; Ilias Alevizos; Xibao Liu; Wiliam D Swaim; Hongen Yin; Stefan Feske; Masatsugu Oh-hora; Indu S Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

7.  Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; César Jiménez-Hernández; Mario Jiménez-Hernández; Arnulfo Nava-Zavala; Carlos Riebeling
Journal:  Int J Clin Rheumtol       Date:  2012-12

8.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

9.  Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.

Authors:  Junji Xu; Dandan Wang; Dayong Liu; Zhipeng Fan; Huayong Zhang; Ousheng Liu; Gang Ding; Runtao Gao; Chunmei Zhang; Yaozhong Ding; Jonathan S Bromberg; Wanjun Chen; Lingyun Sun; Songlin Wang
Journal:  Blood       Date:  2012-08-27       Impact factor: 22.113

10.  In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Takeshi Nitta; Rieko Arakaki; Akiko Yamada; Martin Lipp; Yousuke Takahama; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.